MoneyWorks4Me

Aurobindo Pharma informs about completion of acquisition

15 Dec 2023 Evaluate

With reference to earlier letters dated July 3, 2023 and September 12, 2023 informing about acquisition of certain marketing and manufacturing related authorisations, Aurobindo Pharma has informed that the aforementioned acquisition has been completed on December 15, 2023. 

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1647.00 16.00 (0.98%)
28-Aug-2026 14:27 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1921.45
Dr. Reddys Labs. 1174.70
Cipla 1416.85
Lupin 2171.45
Zydus Lifesciences 1172.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: